[1]蒋姗彤 王宏宇.重视睡眠障碍和慢性炎性相关的血管健康非传统危险因素的管理[J].心血管病学进展,2022,(11):1021.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.013]
　JIANG Shantong,WANG Hongyu.Pay Attention to Management of Non-Traditional Vascular Health Risk Factors Related to Sleep Disorders and Chronic Inflammation[J].Advances in Cardiovascular Diseases,2022,(11):1021.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.013]
点击复制

重视睡眠障碍和慢性炎性相关的血管健康非传统危险因素的管理()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年11期
页码:
1021
栏目:
综述
出版日期:
2022-11-25

文章信息/Info

Title:
Pay Attention to Management of Non-Traditional Vascular Health Risk Factors Related to Sleep Disorders and Chronic Inflammation
作者:
蒋姗彤1 王宏宇 1; 2; 3
(1.北京大学首钢医院血管医学中心,北京 100144;2.北京大学医学部血管健康研究中心,北京 100144;3.分子心血管学教育部重点实验室(北京大学)
Author(s):
JIANG Shantong1;  WANG Hongyu1; 2; 3
(1. Department of Vascular Medicine,Peking University Shougang Hospital,Beijing 100144,China; 2. Vascular Health Research Center of Peking University Health Science Center(VHRC-PKUHSC),Beijing 100144,China; 3.Key Laboratory of Molecular Cardiovascular Sciences,Ministry of Education,Beijing 100191,China)
关键词:
血管健康; 非传统血管健康危险因素; 血管医学
Keywords:
Vascular health; Non-traditional vascular health risk factors; Vascular medicine
DOI:
10.16806/j.cnki.issn.1004-3934.2022.11.013
摘要:
血管相关的心脑和外周血管系统疾病对人类的危害持续不减，改变上述现状需改变以往的诊疗模式，多个系统的疾病状态、亚健康乃至健康状态下的睡眠障碍与慢性炎症等非传统危险因素均能影响人体的血管健康。应从仅关注传统常规危险因素的同时，更加考虑以往未得到足够重视的或未能被识别的危险因素对血管健康的影响。在全面深入了解血管医学学科研究领域的基础上对非传统血管健康危险因素的进一步重视，将为血管相关疾病的防控和血管健康终身维护提供新的思路，开阔新的视野。
Abstract:
Vascular related diseases of the heart,brain and peripheral vascular system sustained injury human health. Changing the above situation requires changing the previous diagnosis and treatment mode. Non-traditional risk factors such as disease status of multiple systems,sleep disorder and chronic inflammation in sub-health and even health status can affect human vascular health. We should pay more attention to the impact on vascular health of risk factors that have not been paid enough attention or not been identified in the past while focusing only on traditional conventional risk factors. Further attention to non-traditional vascular health risk factors based on a comprehensive and in-depth understanding of the research field of vascular medicine will provide new ideas and broaden new horizons for the prevention and control of vascular related diseases and the lifelong maintenance of vascular health

参考文献/References:

[1] 中国医药教育协会血管医学专业委员会,中华医学会北京心血管病学分会血管专业学组,北京大学医学部血管疾病社区防治中心. 中国血管健康评估系统应用指南(2018第三次报告)[J]. 中华医学杂志,2018,98(37):2955-2967.

[2] 蒋姗彤,王宏宇. 基于北京血管健康分级指导的智能化全生命周期心脏和血管健康管理[J]. 中华临床医师杂志(电子版),2019,13(11):868-871.

[3] Liu H,Liu J,Zhao H,et al. The design and rationale of the Beijing Vascular Disease Patients Evaluation Study(BEST study)[J]. Contemp Clin Trials Commun,2017,7:18-22.

[4] Liu H,Liu J,Huang W,et al. Association between multi-site atherosclerotic plaques and systemic arteriosclerosis:results from the BEST study(Beijing Vascular Disease Patients Evaluation Study)[J]. Cardiovasc Ultrasound,2020,18(1):30.

[5] Liu H,Liu J,Zhao H,et al. Relationship between glycated hemoglobin and low Ankle-Brachial Index:a cross-sectional observational study from the Beijing Vascular Disease Evaluation Study(BEST Study)[J]. Int Angiol,2019,38(6):502-507.

[6] Liu H,Liu J,Zhao H,et al. Relationship between serum uric acid and vascular function and structure markers and gender difference in a real-world population of China—From Beijing Vascular Disease Patients Evaluation Study(BEST) Study[J]. J Atheroscler Thromb,2018,25(3):254-261.

[7] Liu H,Xie W,Liu J,et al. Comparison of vascular-related diseases in their associations with carotid femoral pulse wave velocity:from the Beijing Vascular Disease Patients Evaluation Study(BEST Study)[J]. Int J Clin Pract,2019,73(11):e13400.

[8] 王宏宇. 非传统血管健康危险因素管理策略—2019专家观点[M]. 北京:北京大学医学出版社,2020.

[9] Yeghiazarians Y,Jneid H,Tietjens JR,et al. Obstructive sleep apnea and cardiovascular disease:a scientific statement from the American Heart Association[J]. Circulation,2021,144(3):e56-e67.

[10] Salman LA,Shulman R,Cohen JB. Obstructive sleep apnea,hypertension,and cardiovascular risk:epidemiology,pathophysiology,and management[J]. Curr Cardiol Rep,2020,22(2):6.

[11] Liu H,Xie G,Huang W,et al.Rationale and design of a multicenter,randomized,patients-blinded two-stage clinical trial on effects of endothelial function test in patients with non-obstructive coronary artery disease(ENDOFIND)[J]. Int J Cardiol,2021,325:16-22.

[12] Arbab-Zadeh A. Coronary atheroma burden is the main determinant of patient outcome:but how much detail is needed?[J]. Circ Cardiovasc Imaging,2018,11(7):e007992.

[13] Chistiakov DA,Orekhov AN,Bobryshev YV. Links between atherosclerotic and periodontal disease[J]. Exp Mol Pathol,2016,100(1):220-235.

[14] Golia E,Limongelli G,Natale F,et al. Inflammation and cardiovascular disease:from pathogenesis to therapeutic target[J]. Curr Atheroscler Rep,2014,16(9):435.

[15] 徐佳,余周庆,彭治凯,等. 牙周非手术治疗对慢性牙周炎患者内皮功能和动脉僵硬度的影响[J]. 口腔医学研究,2017,33(12):1332-1335.

[16] Aspelund A,Robciuc MR,Karaman S,et al. Lymphatic system in cardiovascular medicine[J]. Circ Res,2016,118(3):515-530.

[17] Henri O,Pouehe C,Houssari M,et al. Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction[J]. Circulation,2016,133(15):1484-1497.

[18] Ishikawa Y,Akishima-Fukasawa Y,Ito K,et al.Lymphangiogenesis in myocardial remodelling after infarction[J]. Histopathology,2007,51(3):345-353.

[19] Lely AT,Salahuddin S,Holwerda KM,et al. Circulating lymphangiogenic factors in preeclampsia[J]. Hypertens Pregnancy,2013,32(1):42-49.

[20] Nykanen AI,Sandelin H,Krebs R,et al. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts[J]. Circulation,2010,121(12):1413-1422.

[21] Taher M,Nakao S,Zandi S,et al. Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis:a regulatory role for soluble VEGF receptor 2[J]. FASEB J,2016,30(7):2490-2499.

[22] Yang GH,Zhou X,Ji WJ et al. Overexpression of VEGF-C attenuates chronic high salt intake-induced left ventricular maladaptive remodeling in spontaneously hypertensive rats[J]. Am J Physiol Heart Circ Physiol,2014,306(4):H598-H609.

[23] 陈捷 ,王宏宇. 淋巴系统与心血管疾病的相关性研究[J]. 心血管病学进展,2021,42(7):586-589.

[24] 刘欢,何映东,刘金波,等. 血管健康指标对新发心脑血管事件的预测价值:北京血管健康分级标准的初步验证[J]. 北京大学学报(医学版),2020,52(3):514-520.

相似文献/References:

[1]于博文 修成奎 王雪 杨静 雷燕.内皮微粒在临床中的研究进展及应用[J].心血管病学进展,2021,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
　YU Bowen,XIU Chengkui,WANG Xue,et al.Research Progress and Application of Endothelial Microparticles in Clinic[J].Advances in Cardiovascular Diseases,2021,(11):76.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]

更新日期/Last Update: 2023-01-31